Arrowhead Pharmaceuticals (ARWR) Stock Price & Financial Analysis
Arrowhead Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Arrowhead Pharmaceuticals
What is the current stock price for ARWR?
As of the latest trading session, ARWR stock trades at $61.03. The 52-week range is $9.57–$76.76, with a day range of $60.41–$63.32.
What is the P/E ratio for ARWR?
Arrowhead Pharmaceuticals's trailing P/E ratio is 43.8, meaning investors pay $43.8 for every $1 of annual earnings. Arrowhead Pharmaceuticals operates in the Healthcare sector.
Does ARWR pay dividends?
Arrowhead Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ARWR?
Based on 8 analysts, the consensus for ARWR is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ARWR?
Arrowhead Pharmaceuticals's market capitalization is $8.59B, classifying it as a mid-cap company. Arrowhead Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.